Integrative Health Approaches for Breast Cancer Survivors
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, it does mention that participants with non-metastatic disease receiving anti-Her2 treatment are eligible, suggesting some treatments may be continued. It's best to discuss your specific medications with the trial coordinators.
What data supports the effectiveness of the treatment Ayurveda Intervention (AVI) and Facing Forward Health Education Intervention (FFHEI) for breast cancer survivors?
Is the Ayurvedic Intervention safe for breast cancer survivors?
How does the Integrative Health Approaches treatment for breast cancer survivors differ from other treatments?
This treatment is unique because it combines Ayurvedic medicine, which focuses on nutrition and lifestyle changes, with a health education intervention, offering a holistic approach to improve quality of life for breast cancer survivors, unlike conventional treatments that primarily focus on medical interventions.12347
What is the purpose of this trial?
This clinical trial is a two-arm pilot randomized controlled trial for non-metastatic breast cancer survivors to determine the feasibility, acceptability, and fidelity of two integrative health approaches and study design in a multi-site setting. Participants (n=104) will be randomized to either the Ayurveda Intervention (AVI) or Facing Forward Health Education Intervention (FFHEI). Integrative health combines biomedical and complementary approaches together in a coordinated way. AVI, a multi-modal intervention, includes nutritional education, lifestyle practices, yoga, and therapeutic touch, called marma, to help the body and mind feel balanced. FFHEI provides health education using self-directed online content and interactive videos based on the latest science in cancer survivorship. This study does not intend to conduct tests of efficacy and is focused on feasibility outcomes.
Research Team
Anand Dhruva, MD
Principal Investigator
University of California, San Francisco
Eligibility Criteria
This trial is for non-metastatic breast cancer survivors. It's designed to see if two different health approaches are practical and well-received in a multi-site setting. Participants must be past the initial treatment phase of their cancer.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the Ayurveda Intervention (AVI) or Facing Forward Health Education Intervention (FFHEI) over 6 months. AVI includes nutrition education, lifestyle practices, yoga, and marma therapeutic touch. FFHEI involves self-directed online health education sessions.
Follow-up
Participants are monitored for safety and effectiveness after treatment. AVI participants may have monthly videoconference visits for 6 months.
Treatment Details
Interventions
- Ayurveda Intervention (AVI)
- Facing Forward Health Education Intervention (FFHEI)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
National Center for Complementary and Integrative Health (NCCIH)
Collaborator